(Update 10AM, 3/21/2017) It's the semifinals, everybody—the Final Four, as they say in football, or whatever. French Pharmacy's Bioderma Crealine squares off against American Drugstore's Pixi Glow Tonic, while the prestigious Armani Luminous Silk Foundation and Drunk Elephant's all-natural C-Firma duke it out. Who heads on to the Finals? That's up to you. Vote below:
Just like Northwestern couldn't beat Gonzaga (we were all that crying kid this weekend, were we not?), Nuxe's Precious Oil didn't stand a chance against La Roche-Posay Effaclar Duo in the second round of ITG's inaugural March Madness competition. You heard it here first, ladies and gents: Never bet against an acne product and expect to win. Other notable matchups and wins:
- Bioderma Crealine's inevitable win didn't come as easily as expected. It eventually did triumph over Embryolisse with 57% of the vote, but showed some key weaknesses against its French pharm fam. Expected a highly contested battle against La Roche-Posay Effaclar Duo this week.
- Maybelline Great Lash is the Duke to Pixi by Petra Glow Tonic's University of South Carolina. Talk about an upset! This is why we do what we do, folks. Raising a glass to the small but mighty Petra fans.
- Maybelline got totally shut out of Round 3, with Baby Lips suffering a surprising loss against Neutrogena Makeup Remover Towelettes. Emily Ferber feels a small bit of redemption after that devastating Lumi Cushion loss in Round 1.
- Y'all don't care much about hair, do you? Oribe Dry Texturizing Spray, the last true haircare product standing, was edged out by Giorgio Armani Luminous Silk Foundation. It was the closest battle of the bunch though, with a 51/49 split. Twitter is turning out some truly nail-biting finishes.
Moving forward, we're changing the rules a little. The rest of the entire tournament will be open to Twitter voting, but with only one day between each remaining round. Let's wrap this shit up, shall we?
As always, an updated bracket:
(Right click to make it big, ya nerd.)
Bracket via ITG. Look back at round 2 here.